Get my own profile
Public access
View all217 articles
12 articles
available
not available
Based on funding mandates
Co-authors
george haskoColumbia UniversityVerified email at cumc.columbia.edu
Partha Mukhopadhyay, MS, Ph.D.National Institutes of HealthVerified email at mail.nih.gov
Sandor Batkai MD, PhDCardior Pharmaceutical GmbHVerified email at cardior.de
Csaba SzaboProfessor, Chair of Pharmacology, University of Fribourg, SwitzerlandVerified email at unifr.ch
Jon MableyUniversity of BrightonVerified email at brighton.ac.uk
George KunosScientific Director, NIAAA/NIHVerified email at nih.gov
Rajesh MohanrajAssistant Professor, Department of Pharmacology and Therapeutics, UAE universityVerified email at uaeu.ac.ae
Zoltan Ungvari, M.D., Ph.D.Vascular Cognitive Impairment & Neurodegeneration Program OUHSCVerified email at ouhsc.edu
Bin GaoChief, Laboratory of Liver Diseases, NIAAA, NIHVerified email at mail.nih.gov
Balazs CsokaCelgeneVerified email at celgene.com
Németh ZoltánVerified email at ladypower.hu
Zoltan VargaSemmelweis University, HCEMMVerified email at med.semmelweis-univ.hu
Katalin Erdelyipost doctoral fellowVerified email at mail.nih.gov
Francisco Garcia SorianoProfessor Associado, Departamento de Clínica Médica da Faculdade de Medicina da Universidade de SăoVerified email at usp.br
Laszlo ViragProfessor of Medical Chemistry, University of Debrecen, Faculty of Medicine, HungaryVerified email at med.unideb.hu
Luca AntonioliDept Clinical and Experimental Medicine University of PisaVerified email at medmcs.unipi.it
Janos PalocziLSU Health Science CenterVerified email at lsuhsc.edu
E. Sylvester Vizi MD, PhD, MHAS, Ho...Hun-Ren Inst. of Experimental Medicine, and Semmelweis University, Department of Pharmacology andVerified email at koki.hu
Ken MackieProfessor Psychological and Brain Sciences, Indiana UniversityVerified email at indiana.edu
Douglas Osei-HyiamanNational Institutes of HealthVerified email at mail.nih.gov